Lopez CM, Yarrarapu SNS, Mendez MD (2023) Food allergies. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing [cited 2023 Jul 26]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK482187/

Loh W, Tang MLK (2018) The epidemiology of food allergy in the global context. Int J Environ Res Public Health [Internet]. [cited 2023 Jul 26];15(9):2043. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163515/ 

Gupta RS, Warren CM, Smith BM, Jiang J, Blumenstock JA, Davis MM et al (2019) Prevalence and severity of food allergies among us adults. JAMA Netw Open 2(1):e185630

Article  PubMed  PubMed Central  Google Scholar 

Patel R, Koterba AP (2023) Peanut allergy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing [cited 2023 Jul 26]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK538526/

Bock SA, Muñoz-Furlong A, Sampson HA (2001) Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 107(1):191–193

Article  CAS  PubMed  Google Scholar 

Krogulska A, Wood RA (2020) Peanut allergy diagnosis: moving from basic to more elegant testing. Pediatr Allergy Immunol 31(4):346–357

Article  PubMed  Google Scholar 

Palladino C, Breiteneder H (2018) Peanut allergens. Mol Immunol [Internet]. [cited 2023 Jul 26]; 100:58–70. Available from: https://www.sciencedirect.com/science/article/pii/S0161589018301226

Who/iuis allergen nomenclature home page [Internet]. [cited 2023 Jul 26]. Available from: http://www.allergen.org/index.php

Dougherty JM, Alsayouri K, Sadowski A (2023) Allergy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing [cited 2023 Jul 26]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK545237/

Shroba J, Rath N, Barnes C (2019) Possible role of environmental factors in the development of food allergies. Clin Rev Allergy Immunol 57(3):303–311

Article  CAS  PubMed  Google Scholar 

Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF et al (2015) Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med 372(9):803–813

Article  PubMed  PubMed Central  Google Scholar 

Eimear O, Hilary T, Andrew C, Andrew L, Sindher S, Sharon CR (2022) Current insights: a systemic review of therapeutic options for peanut allergy. Curr Opin Allergy Clin Immunol [Internet]. [cited 2023 Jul 26];22(3):188–193. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178908/

Bégin P, Chan ES, Kim H, Wagner M, Cellier MS, Favron-Godbout C et al (2020) CSACI guidelines for the ethical, evidence-based and patient-oriented clinical practice of oral immunotherapy in IgE-mediated food allergy. Allergy Asthma Clin Immunol 16:20

Article  PubMed  PubMed Central  Google Scholar 

Chu DK, Wood RA, French S, Fiocchi A, Jordana M, Waserman S et al (2019) Oral immunotherapy for peanut allergy (Pace): a systematic review and meta-analysis of efficacy and safety. Lancet 393(10187):2222–2232

Article  CAS  PubMed  Google Scholar 

Fiocchi A, Artesani MC, Fierro V, Riccardi C, Dahdah L, Mennini M (2020) Oral immunotherapy for peanut allergy: the con argument. World Allergy Organ J [Internet]. [cited 2023 Jul 26];13(8):100445. Available from: https://www.sciencedirect.com/science/article/pii/S1939455120303483

Wang J, Sampson HA (2018) Safety and efficacy of epicutaneous immunotherapy for food allergy. Pediatr Allergy Immunol 29(4):341–349

Article  CAS  PubMed  Google Scholar 

Xiong L, Lin J, Luo Y, Chen W, Dai J (2020) The efficacy and safety of epicutaneous immunotherapy for allergic diseases: a systematic review and meta-analysis. Int Arch Allergy Immunol 181(3):170–182

Article  CAS  PubMed  Google Scholar 

Sun J, Hui X, Ying W, Liu D, Wang X (2014) Efficacy of allergen-specific immunotherapy for peanut allergy: a meta-analysis of randomized controlled trials. Allergy Asthma Proc 35(2):171–177

Article  CAS  PubMed  Google Scholar 

de Silva D, Rodríguez Del Río P, de Jong NW, Khaleva E, Singh C, Nowak-Wegrzyn A et al (2022) Allergen immunotherapy and/or biologicals for IgE-mediated food allergy: a systematic review and meta-analysis. Allergy 77(6):1852–1862

Article  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 29(372):n71

Article  Google Scholar 

Canonica GW, Baena-Cagnani CE, Bousquet J, Bousquet PJ, Lockey RF, Malling HJ et al (2007) Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a World Allergy Organization (Wao) taskforce: recommendations for immunotherapy clinical trials. Allergy [Internet]. [cited 2023 Jul 26];62(3):317–324. Available from: https://onlinelibrary.wiley.com/doi/10.1111/j.1398-9995.2006.01312.x

Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors) (2022) Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane. www.training.cochrane.org/handbook. Accessed 25 Oct 2023

Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J et al (2011) GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. J Clin Epidemiol [Internet]. 64(4):383–394. https://linkinghub.elsevier.com/retrieve/pii/S0895435610003306. Accessed 30 Oct 2023

Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14:135

Article  PubMed  PubMed Central  Google Scholar 

Greenhawt M, Sindher SB, Wang J, O’Sullivan M, Du Toit G, Kim EH, Albright D et al (2023) Phase 3 trial of epicutaneous immunotherapy in toddlers with peanut allergy. N Engl J Med 388(19):1755–1766. https://doi.org/10.1056/NEJMoa2212895

Article  CAS  PubMed  Google Scholar 

Pongracic JA, Gagnon R, Sussman G, Siri D, Oriel RC, Brown-Whitehorn TF, Green TD et al (2022) Safety of epicutaneous immunotherapy in peanut-allergic children: REALISE randomized clinical trial results. The Journal of Allergy and Clinical Immunology: In Practice 10(7):1864–1873.e10. https://doi.org/10.1016/j.jaip.2021.11.017

Article  CAS  PubMed  Google Scholar 

Fleischer DM, Greenhawt M, Sussman G, Bégin P, Nowak-Wegrzyn A, Petroni D, Beyer K et al (2019) Effect of epicutaneous immunotherapy vs placebo on reaction to peanut protein ingestion among children with peanut allergy. JAMA 321(10):946–955. https://doi.org/10.1001/jama.2019.1113

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jones SM, Sicherer SH, Burks AW, Leung DY, Lindblad RW, Dawson P, Henning AK et al (2017) Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults. J Allergy Clin Immunol 139(4):1242–1252.e9. https://doi.org/10.1016/j.jaci.2016.08.017

Article  CAS  PubMed  Google Scholar 

Sampson HA, Shreffler WG, Yang WH, Sussman GL, Brown-Whitehorn TF, Nadeau KC, Cheema AS et al (2017) Effect of varying doses of epicutaneous immunotherapy vs placebo on reaction to peanut protein exposure among patients with peanut sensitivity. JAMA 318(18):1798–1809. https://doi.org/10.1001/jama.2017.16591

Article  PubMed  PubMed Central  Google Scholar 

Jones SM, Agbotounou WK, Fleischer DM, Burks AW, Pesek RD, Harris MW, Martin L, Thebault C, Ruban C, Benhamou PH (2016) Safety of epicutaneous immunotherapy for the treatment of peanut allergy: a phase 1 study using the Viaskin patch. J Allergy Clin Immunol 137(4):1258–1261.e10. https://doi.org/10.1016/j.jaci.2016.01.008

Article  PubMed  Google Scholar 

Brown-Whitehorn TF, de Blay F, Spergel JM, Green TD, Peillon A, Sampson HA, Campbell DE (2021) Sustained unresponsiveness to peanut after long-term peanut epicutaneous immunotherapy. The Journal of Allergy and Clinical Immunology: In Practice 9(1):524–526. https://doi.org/10.1016/j.jaip.2020.08.017

Article  PubMed  Google Scholar 

Fleischer DM, Shreffler WG, Campbell DE, Green TD, Anvari S, Assa’ad A, Bégin P, et al (2020) Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results. J Allergy Clin Immunol 146(4):863–874. https://doi.org/10.1016/j.jaci.2020.06.028

Article  CAS  PubMed  Google Scholar 

Bastin M, Carr WW, Davis CM, Fleischer DM, Lieberman JA, Mustafa SS et al (2023) Immune response evolution in peanut epicutaneous immunotherapy for peanut‐allergic children. Allergy [Internet]. 78(9):2467–2476. https://onlinelibrary.wiley.com/doi/10.1111/all.15709. Accessed Nov 2023

DunnGalvin A, Fleischer DM, Campbell DE, O’B Hourihane J, Green TD, Sampson HA et al (2021) Improvements in quality of life in children following epicutaneous immunotherapy (Epit) for peanut allergy in the pepites and people studies. JACI: In Practice [Internet]. 9(1):216–224.e1. https://linkinghub.elsevier.com/retrieve/pii/S221321982030831X. Accessed Nov 2023

Gupta J, Margolis DJ (2020) Filaggrin gene mutations with special reference to atopic dermatitis. Current Treatment Options in Allergy 7(3):403–413. https://doi.org/10.1007/s40521-020-00271-x

Article  PubMed  PubMed Central  Google Scholar 

(2020) Home • core outcome measures for food allergy [Internet]. European Cooperation in Science and Technology (COST). https://comfa.eu/. Accessed Dec 2023

Shaker M, Greenhawt M (2019) Estimation of health and economic benefits of commercial peanut immunotherapy products: a cost-effectiveness analysis. JAMA Network Open 2(5):e193242

Article  PubMed  PubMed Central  Google Scholar